Stay updated on Avadomide and Nivolumab Combo in Adv Melanoma Clinical Trial

Sign up to get notified when there's something new on the Avadomide and Nivolumab Combo in Adv Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Avadomide and Nivolumab Combo in Adv Melanoma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The footer's ClinicalTrials.gov revision label changes from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-13T14:53:01.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error, replacing the detailed study record with only a minimal header and a Home link. The core content such as the title, summary, eligibility criteria, and outcomes is no longer accessible.
    Difference
    18%
    Check dated 2026-09-22T22:23:14.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.6 to v3.7.0, signaling a site update while preserving the displayed study information.
    Difference
    0.1%
    Check dated 2026-09-15T21:46:22.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    Deleted the MedlinePlus related topics header and its entries for Melanoma and MedlinePlus Genetics from the page, removing quick-access links to these related topics.
    Difference
    0.2%
    Check dated 2026-09-08T18:47:58.000Z thumbnail image
  7. Check
    44 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.5 to v3.6.6, indicating a small behind-the-scenes update to the page without changing the visible study details.
    Difference
    0.1%
    Check dated 2026-09-01T18:35:39.000Z thumbnail image
  8. Check
    58 days ago
    Change Detected
    Summary
    The page adds Melanoma as a related topic and includes MedlinePlus Genetics as a related topics resource, enriching disease context and linkage to genetics information for readers.
    Difference
    0.2%
    Check dated 2026-08-18T19:23:02.000Z thumbnail image

Stay in the know with updates to Avadomide and Nivolumab Combo in Adv Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Avadomide and Nivolumab Combo in Adv Melanoma Clinical Trial page.